Hi-Tech Pharmacal announces pending application amendment for Albuterol Sulfate Inhalation Solution 0.5% to be manufactured under sterile conditions.
Business Wire › November 06, 1996
Linked as:
Extract
Hi-Tech Pharmacal announces pending application amendment for Albuterol Sulfate Inhalation Solution 0.5% to be manufactured under sterile conditions.
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Nov. 6, 1996--Hi-Tech Pharmacal Co. Inc. (NASDAQ:HITK) has today announced that their AN...
See the full content of this document
Sponsored links
